ESCMID COVID-19 living guidelines: drug treatment and clinical management

In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19. An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was establish...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical microbiology and infection 2022-02, Vol.28 (2), p.222-238
Hauptverfasser:	Bartoletti, Michele, Azap, Ozlem, Barac, Aleksandra, Bussini, Linda, Ergonul, Onder, Krause, Robert, Paño-Pardo, José Ramón, Power, Nicholas R., Sibani, Marcella, Szabo, Balint Gergely, Tsiodras, Sotirios, Verweij, Paul E., Zollner-Schwetz, Ines, Rodríguez-Baño, Jesús
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - therapeutic use Antibodies, Neutralizing - therapeutic use Antiviral Agents - therapeutic use COVID-19 COVID-19 - drug therapy COVID-19 - therapy Disease progression Guidelines Humans Immunization, Passive Mortality Practice Guidelines as Topic SARS-CoV-2 Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!